Drug that targets ACE2 receptors may work against new covid variants

A drug that is approved for treating gallstones and liver conditions inhibits cells' ACE2 receptors, which the coronavirus' spike protein binds to

Related Keywords

United Kingdom ,Cambridge ,Cambridgeshire ,Fotios Sampaziotis ,Carissa Wong ,University Of Cambridge ,Alamy ,Medical Drugs ,Coronavirus ,Covid 19 ,Sars Cov 2 ,